Fig. 3From: An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discoveryValidation of MAOS and MAPS signatures in training and validation datasets. (A and B) Kaplan-Meier plots and the receiver operating characteristic (ROC) curve of MAOS in GSE39582 and GSE17536 validation sets. (C and D) Kaplan-Meier plots and ROC curve of MAPS in the two validation datasets (GSE39582 and GSE17536). (E and F) The multivariate Cox analysis of the MAOS and MAPS signature with other clinicopathological factors in the training TYGA-COAD datasets and two validation datasets (GSE39582 and GSE17536), respectivelyBack to article page